Placeholder Banner

BIO Joins Alliance to Protect Medical Innovation

October 4, 2018

BIO Joins Alliance to Protect Medical Innovation

Biotechnology Innovation Organization (BIO) Director of Communications Brian Newell released the following statement:

“BIO has joined the Alliance to Protect Medical Innovation. Small company innovators are at the center of the biopharmaceutical industry, and they will be disproportionately impacted by the flawed policies often touted as the way to lower the cost of prescription drugs. Innovation and bad public policy cannot coexist. That’s an important message often neglected in the debate about health care costs, and that’s precisely the message this organization will help deliver.”

Discover More
BIO to Transition Agricultural and Environmental Biotech Workstreams  Key Senior Hires Bolster Focus on Regulatory Affairs, Emerging Companies   and Economic Growth   Washington, DC, May 28, 2025 – The Biotechnology Innovation…
“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the United States and the cornerstone of America’s…
WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks…